IL6 and Sepsis: In another study addressing also the mouse CLP sepsis model, XBJI administration significantly improved renal microvascular perfusion and oxygenation and inhibited renal expression of IL-1β, IL-6, TNF-α, and high mobility group box 1 (HMGB1) protein, although without affecting the survival rate (Liu J et al., 2021).